Author:
Mutimura Eugene,Stewart Aimee,Crowther Nigel J.,Yarasheski Kevin E.,Cade W. Todd
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference46 articles.
1. Egger, M., May, M., Chene, G., et al. (2002). Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet, 360, 119–129.
2. Chen, D., Mistra, A., & Garg, A. (2002). Lipodystrophy in human immunodeficiency virus-infected patients. The Journal of Clinical Endocrinology and Metabolism, 87, 4845–4856.
3. Pujari, S. N., Dravid, A., Naik, E., et al. (2005). Lipodystrophy and dyslipidaemia among patients taking first-line, World Health Organisation-recommended highly active antiretroviral therapy regimens in Western India. Journal of Acquired Immune Deficiency Syndromes, 39, 199–202.
4. Reynolds, N. R., Neidig, J. L., Wu, A. W., et al. (2006). Balancing disfigurement and fear of disease progression: Patient perceptions of HIV fat redistribution. AIDS Care, 18, 663–673.
5. Beck, E. J., Vitoria, M., Mandalia, S., et al. (2006). National adult antiretroviral therapy guidelines in resource-limited countries: Concordance with 2003 WHO guidelines? AIDS, 11, 1497–1502.
Cited by
81 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献